{"name":"Daewoong Bio Inc.","slug":"daewoong-bio-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Choline Alfoscerate 400mg","genericName":"Choline Alfoscerate 400mg","slug":"choline-alfoscerate-400mg","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Choline Alfoscerate 400mg","genericName":"Choline Alfoscerate 400mg","slug":"choline-alfoscerate-400mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxORkhya3VZZFdTM0c5cDFUWVNQVjRaUnRwYXNNcjJHNTN6WnEzMVRKOWV2WGtXcUttYVJTa3diWDlwRUxJc2ZSQVBwRWwwRG5TYWg5cUtrbnEwTFhpZm04bV9peUxVaUNraU1hb3lLNmN2cHZaLW5vbm5odXQ0ZjhKTW03NS01RU5h?oc=5","date":"2025-11-26","type":"pipeline","source":"조선일보","summary":"AI Cuts South Korea's Drug Development Time from 10 to 2-3 Years - 조선일보","headline":"AI Cuts South Korea's Drug Development Time from 10 to 2-3 Years - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPODczeUVMOVFkcFJjV2pDLWpYT25sQ1lucFJFVjJQTDdNOEF5dm5neVU5b0p6U3drR0JMaXI2UUM0eDJlcjRLTEo5c2hzTDNyZkt6bEE2WGRSSVI1eEVSZlhIbkwxOWQ1dVd3Vk04NktnbWZzTnJZckp1RzdYV2RfRjFmMUJTUFI1MXNLOE5lOGtGZDRWRjBwUTlsU2tWczA?oc=5","date":"2025-11-04","type":"pipeline","source":"BioWorld News","summary":"CG Bio, Nexgel developing long-acting drug delivery system - BioWorld News","headline":"CG Bio, Nexgel developing long-acting drug delivery system","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPVlo0UlJ3YmZfN1Foa3J1end3NHMyb0hXekVqQ0h3X2l6SVFwcnZlQkdGNXhqZzFGZWMwTUxxZkU5QTBZcUNGNDRheUIxWWVkMkZySm9qMXU0bnVadmVaMGRHdEF6RjU3SDJWM0VqNWQyaUJlUkNWY3puLUNIb1pSbk1HZEtBZFNkdmlkN1EzTmM4bjFkNkFpRHc0NjlZRnpWMDE1VGhkUzg?oc=5","date":"2025-06-17","type":"deal","source":"BioWorld News","summary":"Korea biotech roundup: four financings, six R&D deals mid-June - BioWorld News","headline":"Korea biotech roundup: four financings, six R&D deals mid-June","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBvNXZxeUpWaHRMZ3pjRzNHVnVLc09naUFzTjVUWUZpUjJQaFdwYXplb3owamc3QmRfUjc3UmdaMV9DeDJ4c1puclQxOGtHNk53Rk9ITVI2MA?oc=5","date":"2025-06-09","type":"pipeline","source":"The Korea Herald","summary":"CGBio launches China joint venture to expand regenerative medicine reach - The Korea Herald","headline":"CGBio launches China joint venture to expand regenerative medicine reach","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBKYWFkenNWeUMyYTlPSW1vWHdrZ21nMi1zNy1hTTZtLS04Q05zajA2NDR2WXI3eWR3V2gzeGRoeGoyNXhteGVNemtrcURtWU9VdkJqbmVhNmNQRmVOZ3JVTHB3UlNEXzRiN1l2QjJR0gFyQVVfeXFMTWZhS3FfekdReU16REhPVURDQzVmcllWN2tFdWVPd01MTnY5OHVwazVHMENEaUY0dklCUHNlU2NVdDJVSTh0Q240MG1xX2VlTGxDbEhqSHNrNDZjWlJOV1pjMFc3M1BqUU84NjE5bFVTejlB?oc=5","date":"2024-11-15","type":"deal","source":"koreabiomed.com","summary":"Daewoong may end licensing deal with Vitalli Bio for autoimmune drug candidate - koreabiomed.com","headline":"Daewoong may end licensing deal with Vitalli Bio for autoimmune drug candidate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQUnZDUV9wRFUwZDFMMUZRcV9FRVpUZGl3MXVTdF9mNW1GVFVFdk4tYmoyM2EtTDNPel9SOW82eEJNWVhNU2trLWRUQkU4WjdnRzNvcXlsNG5zMTdocUpDazJFSE5sTTZ5aDNPYTJSOUpJbmxzRl9uOE1wNmFVelVPY2M5akY1LVRfYUc4S2tFZFk3T0xvZ0pXeVloTk9CTEU?oc=5","date":"2024-11-15","type":"deal","source":"BioWorld News","summary":"Vitalli terminates $477M Daewoong deal, retains $941M option - BioWorld News","headline":"Vitalli terminates $477M Daewoong deal, retains $941M option","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxNUlA1M1U4WjVBcGdjZEREbkpLMTJuQ0tSa3p6Z29lRWptNkFyV25iYzlQeU1kLUVNcXpvN3ZYZzhyc3hRc1dtOGlIeE5pR1UzY0dfeXZPOFoxREdvcm5xSzlZcnVIaXVWUGZtMEswZG1iUEFWcjlqMFJZeEJ6bUY1MHh1WFZrclQzYlFERTR2d2R2THFjR2dCV09VNDFQZzZERmVFeURCdl9LMHEyNFExUG1VZldtVHgxY0VzUW1ZYm8zdjNZLXJxTDFqajNlU0ViYk5GOTNjYXBTT3lHdWJjNjNOaU9BQW5SSGlqV3RXTGRYSDlzMmJxMXpUbmJPMlhmdElDOE9EczR5LTRFOHJ4WUQxcUxYOFhyZVE?oc=5","date":"2024-10-10","type":"pipeline","source":"BioSpace","summary":"Daewoong Pharmaceutical Unveils 'Innovative Drug Delivery Technologies' in Milan--From World's First Microneedle Therapy to Once-a-Month Obesity Treatment - BioSpace","headline":"Daewoong Pharmaceutical Unveils 'Innovative Drug Delivery Technologies' in Milan--From World's First Microneedle Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8yZHpMN3UwNXZXZnJxUmJLZlhSdmp5VXlVSEZnalVEZVhPV1dGd24zalc5ekFsTlJudmZaWUVxSEtLWTBHWWk4bUhzeTJ1TERfdzFjWnNvZUx6R0FWMWdOdWRnMlFDVGltMF94bDRR0gFyQVVfeXFMUDhDQ3VMdEpVUzlJcmJCaU9rWm9qZ0NrQ1U3ZnlrQ2c2MUVpcWo3M3lzQ3lDcmw0dTZyN2FjTHhiaFpNMkY3OFg0TTFqLXBBMG5VVHFUZ0JSS05tWUFOOV9JLU5McmNEM2FkaEJRb1lHYk93?oc=5","date":"2024-07-03","type":"pipeline","source":"koreabiomed.com","summary":"Daewoong Bio expands into biopharmaceutical CMO business - koreabiomed.com","headline":"Daewoong Bio expands into biopharmaceutical CMO business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFBMZ2toYWxFTThaaXRCOFluUlF1R0Q0LUtIMnNhd2ExWDZNSk1vMm96aFRzRUkyeWdlV3RWaWR5U1ozZ3drcjJ5MlpHZEdJYnNYb202RGtvb2Y?oc=5","date":"2023-07-16","type":"pipeline","source":"theinvestor.co.kr","summary":"Daewoong Bio set to ramp up antibiotics biz to W100b in value - theinvestor.co.kr","headline":"Daewoong Bio set to ramp up antibiotics biz to W100b in value","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwJBVV95cUxQSFB5N2dQbW5FUHdTQVN1bTlYOTBRQXd3c0tkcEM5VG42NV9FS3lKeWliTnR6VDhuSXYxeUNtTjZiSHVwakNRRkNQUkg5SWxRRG1IblhkOXFWOHYxd2FReEpmVlZCY1hZczI2MDZKWGtNU1dkUzk4ZEM5RXZBSnZWcnVsNDZKZGI3VTlEZ1BJSGJUd3B2RDZObU1lc24zS293VFc4NkRYOXZ0Z09Wd0NBMDhfeHJMYXIyRl9ndnFiUmdMZzJaRENLQ0J6NUxUX1N3ODRfdVd2Z29WdXUtZGwxcHdJMnF3WXhyUG1lV0tEeHE3eGtDVW1fM1MyT0JPRmRrY0NuMTJYSDJ0S3VWUWRUal82U0Z5N2lGZWdR?oc=5","date":"2023-04-27","type":"deal","source":"PR Newswire","summary":"Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease with Vitalli Bio - PR Newswire","headline":"Daewoong Pharmaceutical announces a Global License Agreement for DWP213388, a new drug candidate for autoimmune disease ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBaeGJUNTNPMUFNZVZ3Q0NycHM0VkIyR1pQeEd4dW9WWHVNdzkzU1cxWlRSTDRQU0hGWGxNNjdjVXhuV0NISkpMWFpvMktzNktVWHRFb3VVa0Q2YXRTODJYam9Wb1QzdHVyNUlfeG53?oc=5","date":"2023-04-03","type":"pipeline","source":"KED Global","summary":"Lotte Biologics, Excellgene to collaborate on CDO biz - KED Global","headline":"Lotte Biologics, Excellgene to collaborate on CDO biz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9xSWNkY29LMmpqRTJPRXI1eUZMMGVwVUlsRmYwejZSRUxZem1mYWVIRVhLcV9sVUN3MVZHMktqQWU5dVAyYldjTDhNMWpSNXM5SU4yWkNCZEtrQ0d6NjA0anFJRmt3LXExdFVHRVJn?oc=5","date":"2023-02-24","type":"pipeline","source":"KED Global","summary":"Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico - KED Global","headline":"Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}